Drug Profile
Poliovirus vaccine inactivated paediatric - GlaxoSmithKline
Alternative Names: IPV vaccine - GlaxoSmithKline; PoliorixLatest Information Update: 08 Sep 2021
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GlaxoSmithKline; GSK
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Poliomyelitis
Most Recent Events
- 08 Sep 2021 Discontinued - Phase-III for Poliomyelitis (In children, In infants, Prevention) in China (IM)
- 08 Jul 2010 GlaxoSmithKline completes a phase III trial (NCT01021293) in Poliomyelitis (prevention, in infants) in China